Oxygen Concentrators Market by Technology (Pulse Flow and Continuous Flow), Product (Portable and Fixed), End User (Hospital, Home Healthcare, and Ambulatory Surgical Centers & Physician Offices): Global Opportunity Analysis and Industry Forecast, 2021–2030
- ALL4676809
- 200 Pages
- August 2021
- Medical Devices
An oxygen concentrator works by filtering and concentrating oxygen molecules from the ambient air to provide patients with 90% to 95% pure oxygen. The compressor of the oxygen concentrator sucks ambient air and adjusts the pressure at which it is provided. It is significantly utilized in homecare settings and is generally preferred by old patients who experience issues in mobility and rely upon a reliable oxygen supply.
Some basic chronic medical conditions, such as chronic obstructive pulmonary diseases (COPD), emphysema, and chronic bronchitis, and typical long-term impact of smoking, require oxygen treatment or supplemental oxygen to get enough oxygen. Furthermore, different kinds of oxygen systems are utilized to convey controlled measure of oxygen to patients. In addition, medical oxygen gas has high purity oxygen that is utilized for clinical treatments and is produced for use in the human body.
Furthermore, rise in prevalence of COVID-19 cases across the globe and growth in number of cases of chronic diseases supplement the market growth. Optimal medical infrastructure utilization has become a high priority for governments worldwide during the COVID-19 pandemic. Furthermore, special attention is drawn to both importers and local manufacturers of medical oxygen gas systems to ensure its uninterrupted supply to designated COVID-19 hospitals identified by local administration. For instance, as per Worldometer, as of April 27th, 2021, there were 19,172,322 active cases of COVID-19 across the globe.
Thus, oxygen concentrators are required for increasing the demand from medical clinics and home care settings. Oxygen concentrators are available in various sizes depending on requirement. In hospitals, oxygen gas treatment is executed on patients for therapy of chronic health issues to improve energy levels, for rest, and superior quality life of patients. Oxygen is generally utilized in medical clinics for therapy of various intense and chronic diseases. These clinical oxygen chambers are generally utilized in ambulances to manage emergency circumstances. Oxygen concentrators have huge need for patients facing different infections such as asthma and chronic diseases.
Population living in poor quality neighborhoods and homes, which lack adequate provision for sanitation, water, garbage removal, and drainage, are specifically susceptible to respiratory disorders such as COPD and asthma. Use of kerosene lights and portable stoves for heating and cooking result in inhalation of particulates. This can cause prolong respiratory diseases such as COPD and asthma among population of underdeveloped regions such as Asia- Pacific and LAMEA. Further, women and children are specifically prone to COPD and asthma as they deal with many indoor tasks. Hence, such factors felicitate demand for home care or portable oxygen concentrators and further boost the market growth.
Women generally spend longer time indoors compared to men and hence are at higher level of risk of developing respiratory disorders. In developed as well as developing regions, people who smoke indoors endanger their family members along with themselves. Thus, rise in indoor pollution causes chronic and respiratory diseases, which is expected to supplement demand for oxygen concentrators
However, high cost of oxygen concentrators hampers the market growth. Moreover, rise in investments in healthcare and increase in technological development in oxygen concentrators offer ample opportunities for further growth of the market.
The global oxygen concentrators market is segmented on the basis of technology, product, end user, and region. By technology, the market is categorized into pulse flow and continuous flow. By product, it is bifurcated into portable and fixed. By end user, it is divided into hospital, home healthcare, and ambulatory surgical centers & physician offices. By region, it is analyzed across North America, Europe, Asia-Pacific, and LAMEA.
Some of the major companies that operate in the global oxygen concentrators market include Koninklijke Philips N.V., Invacare Corporation, DeVilbiss Healthcare LLC, Inogen, Inc., Chart Industries, Inc. (AirSep), Nidek Medical, O2 Concepts, Teijin Limited, Supera Anesthesia Innovations, and GCE Group.
KEY BENEFITS FOR STAKEHOLDERS
• This report provides an extensive analysis of the current and emerging market trends and dynamics in the global oxygen concentrators market to identify the prevailing opportunities.
• This study presents the competitive landscape of the global oxygen concentrators market to predict the competitive environment across regions.
• Comprehensive analysis of factors that drive and restrict the market growth is provided.
• Region & country-wise analysis is provided to understand the market trends and dynamics.
KEY MARKET SEGMENTS
By Technology
• Pulse Flow
• Continuous Flow
By Product
• Portable
• Fixed
By End User
• Hospital
• Home Healthcare
• Ambulatory Surgical Centers & Physician Offices
By Region
o North America
U.S.
Canada
Mexico
o Europe
Germany
France
UK
Italy
Spain
Rest of Europe
o Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
o LAMEA
Brazil
Saudi Arabia
South Africa
Rest of LAMEA
KEY MARKET PLAYERS
• Koninklijke Philips N.V.
• Invacare Corporation
• DeVilbiss Healthcare LLC
• Inogen, Inc.
• Chart Industries, Inc. (AirSep)
• Nidek Medical
• O2 Concepts
• Teijin Limited
• Supera Anesthesia Innovations
• GCE Group
1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology
1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
CHAPTER 2:EXECUTIVE SUMMARY
2.1.Key findings of the study
2.2.CXO perspective
CHAPTER 3:MARKET OVERVIEW
3.1.Market definition and scope
3.2.Key findings
3.2.1.Top investment pockets
3.3.Porter’s five forces analysis
3.3.1.Top player positioning
3.4.2.Drivers
3.4.2.1.Daily exposure to environmental pollution
3.4.2.2.Increase in population susceptible to indoor air pollutants
3.4.2.3.Increase in population of active smokers
3.4.3.Restraints
3.4.3.1.Stringent regulatory procedures
3.4.3.2.High costs of oxygen concentrators
3.4.4.Opportunities
3.4.4.1.High growth potential in emerging markets
3.4.4.2.Increase in geriatric population
3.5.Impact of COVID-19 on oxygen concentrators market
3.5.1.Overview
3.5.2.Impact analysis
CHAPTER 4:OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY
4.1.Overview
4.1.1.Market size and forecast
4.2.Pulse Flow
4.2.1.Key market trends and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country
4.2.3.1.Market size and forecast for pulse flow, by end user
4.3.Continuous Flow
4.3.1.Key market trends and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country
4.3.3.1.Market size and forecast for continuous flow, by end user
CHAPTER 5:OXYGEN CONCENTRATORS MARKET, BY PRODUCT
5.1.Overview
5.1.1.Market size and forecast
5.2.Portable
5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country
5.3.Fixed
5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country
CHAPTER 6:OXYGEN CONCENTRATORS MARKET, BY END USER
6.1.Overview
6.1.1.Market size and forecast
6.2.Hospital
6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country
6.3.Home Healthcare
6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country
6.4.Ambulatory Surgical Centers & Physician Offices
6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country
CHAPTER 7:OXYGEN CONCENTRATORS MARKET, BY REGION
7.1.Overview
7.1.1.Market size and forecast
7.2.North America
7.2.1.Key opportunities and forecast
7.2.2.Market size and forecast, by country
7.2.3.Market size and forecast, by technology
7.2.4.Market size and forecast, by product
7.2.5.Market size and forecast, by end user
7.2.5.1.U.S.
7.2.5.1.1.U.S market size and forecast, by technology
7.2.5.1.2.U.S market size and forecast, by product
7.2.5.1.3.U.S market size and forecast, by end user
7.2.5.2.Canada
7.2.5.2.1.Canada market size and forecast, by technology
7.2.5.2.2.Canada market size and forecast, by product
7.2.5.2.3.Canada market size and forecast, by end user
7.2.5.3.Mexico
7.2.5.3.1.Mexico market size and forecast, by technology
7.2.5.3.2.Mexico market size and forecast, by product
7.2.5.3.3.Mexico market size and forecast, by end user
7.3.Europe
7.3.1.Key opportunities and forecast
7.3.2.Market size and forecast, by country
7.3.3.Market size and forecast, by technology
7.3.4.Market size and forecast, by product
7.3.5.Market size and forecast, by end user
7.3.5.1.Germany
7.3.5.1.1.Germany market size and forecast, by technology
7.3.5.1.2.Germany market size and forecast, by product
7.3.5.1.3.Germany market size and forecast, by end user
7.3.5.2.France
7.3.5.2.1.France market size and forecast, by technology
7.3.5.2.2.France market size and forecast, by product
7.3.5.2.3.France market size and forecast, by end user
7.3.5.3.UK
7.3.5.3.1.UK market size and forecast, by technology
7.3.5.3.2.UK market size and forecast, by product
7.3.5.3.3.UK market size and forecast, by end user
7.3.5.4.Italy
7.3.5.4.1.Italy market size and forecast, by technology
7.3.5.4.2.Italy market size and forecast, by product
7.3.5.4.3.Italy market size and forecast, by end user
7.3.5.5.Spain
7.3.5.5.1.Spain market size and forecast, by technology
7.3.5.5.2.Spain market size and forecast, by product
7.3.5.5.3.Spain market size and forecast, by end user
7.3.5.6.Rest of Europe
7.3.5.6.1.Rest of Europe market size and forecast, by technology
7.3.5.6.2.Rest of Europe market size and forecast, by product
7.3.5.6.3.Rest of Europe market size and forecast, by end user
7.4.Asia-Pacific
7.4.1.Key opportunities and forecast
7.4.2.Market size and forecast, by country
7.4.3.Market size and forecast, by technology
7.4.4.Market size and forecast, by product
7.4.5.Market size and forecast, by end user
7.4.5.1.Japan
7.4.5.1.1.Japan market size and forecast, by technology
7.4.5.1.2.Japan market size and forecast, by product
7.4.5.1.3.Japan market size and forecast, by end user
7.4.5.2.China
7.4.5.2.1.China market size and forecast, by technology
7.4.5.2.2.China market size and forecast, by product
7.4.5.2.3.China market size and forecast, by end user
7.4.5.3.Australia
7.4.5.3.1.Australia market size and forecast, by technology
7.4.5.3.2.Australia market size and forecast, by product
7.4.5.3.3.Australia market size and forecast, by end user
7.4.5.4.India
7.4.5.4.1.India market size and forecast, by technology
7.4.5.4.2.India market size and forecast, by product
7.4.5.4.3.India market size and forecast, by end user
7.4.5.5.Rest of Asia-Pacific
7.4.5.5.1.Rest of Asia-Pacific market size and forecast, by technology
7.4.5.5.2.Rest of Asia-Pacific market size and forecast, by product
7.4.5.5.3.Rest of Asia-Pacific market size and forecast, by end user
7.5.LAMEA
7.5.1.Key opportunities and forecast
7.5.2.Market size and forecast, by country
7.5.3.Market size and forecast, by technology
7.5.4.Market size and forecast, by product
7.5.5.Market size and forecast, by end user
7.5.5.1.Brazil
7.5.5.1.1.Brazil market size and forecast, by technology
7.5.5.1.2.Brazil market size and forecast, by product
7.5.5.1.3.Brazil market size and forecast, by end user
7.5.5.2.Saudi Arabia
7.5.5.2.1.Saudi Arabia market size and forecast, by technology
7.5.5.2.2.Saudi Arabia market size and forecast, by product
7.5.5.2.3.Saudi Arabia market size and forecast, by end user
7.5.5.3.South Africa
7.5.5.3.1.South Africa market size and forecast, by technology
7.5.5.3.2.South Africa market size and forecast, by product
7.5.5.3.3.South Africa market size and forecast, by end user
7.5.5.4.Rest of LAMEA
7.5.5.4.1.Rest of LAMEA market size and forecast, by technology
7.5.5.4.2.Rest of LAMEA market size and forecast, by product
7.5.5.4.3.Rest of LAMEA market size and forecast, by end user
CHAPTER 8:COMPANY PROFILES
8.1.CHART INDUSTRIES, INC.
8.1.1.Company overview
8.1.2.Operating business segments
8.1.3.Product portfolio
8.1.4.Business performance
8.2.DEVILBISS HEALTHCARE
8.2.1.Company overview
8.2.2.Operating business segments
8.2.3.Product portfolio
8.3.GCE Group
8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.4.INOGEN, INC.
8.4.1.Company overview
8.4.2.Product portfolio
8.4.3.Business performance
8.5.INVACARE CORPORATION
8.5.1.Company overview
8.5.2.Operating business segments
8.5.3.Product portfolio
8.5.4.Business performance
8.6.KONINKLIJKE PHILIPS N.V.
8.6.1.Company overview
8.6.2.Operating business segments
8.6.3.Product portfolio
8.6.4.Business performance
8.7.NIDEK MEDICAL PRODUCTS, INC
8.7.1.Company overview
8.7.2.Operating business segments
8.7.3.Product portfolio
8.8.O2 CONCEPTS, Inc.
8.8.1.Company overview
8.8.2.Product portfolio
8.9.Supera Anesthesia Innovations
8.9.1.Company overview
8.9.2.Product portfolio
8.10.Teijin Limited
8.10.1.Company overview
8.10.2.Operating business segments
8.10.3.Product portfolio
8.10.4.Business performance
TABLE 01.OXYGEN CONCENTRATORS MARKET REVENUE, BY TECHNOLOGY, 2020–2030 ($MILLION)
TABLE 02.OXYGEN CONCENTRATORS MARKET REVENUE FOR PULSE FLOW, BY REGION, 2020–2030 ($MILLION)
TABLE 03.OXYGEN CONCENTRATORS MARKET REVENUE FOR PULSE FLOW, BY END USER, 2020–2030 ($MILLION)
TABLE 04.OXYGEN CONCENTRATORS MARKET REVENUE FOR CONTINUOUS FLOW, BY REGION, 2020–2028($MILLION)
TABLE 05.OXYGEN CONCENTRATORS MARKET REVENUE FOR CONTINUOUS FLOW, BY END USER, 2020–2030 ($MILLION)
TABLE 06.OXYGEN CONCENTRATORS MARKET REVENUE, BY PRODUCT, 2020–2030($MILLION)
TABLE 07.OXYGEN CONCENTRATORS MARKET REVENUE FOR PORTABLE, BY REGION, 2020–2030($MILLION)
TABLE 08.OXYGEN CONCENTRATORS MARKET REVENUE FOR FIXED, BY REGION, 2020–2030 ($MILLION)
TABLE 09.OXYGEN CONCENTRATORS MARKET REVENUE, BY END USER, 2020–2030($MILLION)
TABLE 10.OXYGEN CONCENTRATORS MARKET REVENUE FOR HOSPITAL, BY REGION, 2020–2030($MILLION)
TABLE 11.OXYGEN CONCENTRATORS MARKET REVENUE FOR HOME HEALTHCARE, BY REGION, 2020–2030($MILLION)
TABLE 12.OXYGEN CONCENTRATORS MARKET REVENUE FOR AMBULATORY SURGICAL CENTERS & PHYSICIAN OFFICES, BY REGION, 2020–2030($MILLION)
TABLE 13.OXYGEN CONCENTRATORS MARKET, BY REGION, 2020–2030($MILLION)
TABLE 14.NORTH AMERICA OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2020–2030($MILLION)
TABLE 15.NORTH AMERICA OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2020–2030($MILLION)
TABLE 16.NORTH AMERICA OXYGEN CONCENTRATORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 17.NORTH AMERICA OXYGEN CONCENTRATORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 18.U.S OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2020–2030($MILLION)
TABLE 19.U.S OXYGEN CONCENTRATORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 20.U.S OXYGEN CONCENTRATORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 21.CANADA OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2020–2030($MILLION)
TABLE 22.CANADA. OXYGEN CONCENTRATORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 23.CANADA OXYGEN CONCENTRATORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 24.MEXICO OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2020–2030($MILLION)
TABLE 25.MEXICO OXYGEN CONCENTRATORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 26.MEXICO OXYGEN CONCENTRATORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 27.EUROPE OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2020–2030($MILLION)
TABLE 28.EUROPE OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2020–2030($MILLION)
TABLE 29.EUROPE OXYGEN CONCENTRATORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 30.EUROPE OXYGEN CONCENTRATORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 31.GERMANY OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2020–2030($MILLION)
TABLE 32.GERMANY OXYGEN CONCENTRATORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 33.GERMANY OXYGEN CONCENTRATORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 34.FRANCE OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2020–2030($MILLION)
TABLE 35.FRANCE OXYGEN CONCENTRATORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 36.FRANCE OXYGEN CONCENTRATORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 37.UK OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2020–2030($MILLION)
TABLE 38.UK OXYGEN CONCENTRATORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 39.UK OXYGEN CONCENTRATORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 40.ITALY OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2020–2030($MILLION)
TABLE 41.ITALY OXYGEN CONCENTRATORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 42.ITALY. OXYGEN CONCENTRATORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 43.SPAIN OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2020–2030($MILLION)
TABLE 44.SPAIN OXYGEN CONCENTRATORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 45.SPAIN OXYGEN CONCENTRATORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 46.REST OF EUROPE OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2020–2030($MILLION)
TABLE 47.REST OF EUROPE OXYGEN CONCENTRATORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 48.REST OF EUROPE OXYGEN CONCENTRATORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 49.ASIA-PACIFIC OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2020–2030($MILLION)
TABLE 50.ASIA-PACIFIC OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2020–2030($MILLION)
TABLE 51.ASIA-PACIFIC OXYGEN CONCENTRATORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 52.ASIA-PACIFIC OXYGEN CONCENTRATORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 53.JAPAN OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2020–2030($MILLION)
TABLE 54.JAPAN OXYGEN CONCENTRATORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 55.JAPAN OXYGEN CONCENTRATORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 56.CHINA OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2020–2030($MILLION)
TABLE 57.CHINA OXYGEN CONCENTRATORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 58.CHINA OXYGEN CONCENTRATORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 59.AUSTRALIA OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2020–2030($MILLION)
TABLE 60.AUSTRALIA OXYGEN CONCENTRATORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 61.AUSTRALIA OXYGEN CONCENTRATORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 62.INDIA OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2020–2030($MILLION)
TABLE 63.INDIA OXYGEN CONCENTRATORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 64.INDIA OXYGEN CONCENTRATORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 65.REST OF ASIA-PACIFIC OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2020–2030($MILLION)
TABLE 66.REST OF ASIA-PACIFIC OXYGEN CONCENTRATORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 67.REST OF ASIA-PACIFIC OXYGEN CONCENTRATORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 68.LAMEA OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2020–2030($MILLION)
TABLE 69.LAMEA OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2020–2030($MILLION)
TABLE 70.LAMEA OXYGEN CONCENTRATORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 71.LAMEA OXYGEN CONCENTRATORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 72.BRAZIL OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2020–2030($MILLION)
TABLE 73.BRAZIL OXYGEN CONCENTRATORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 74.BRAZIL OXYGEN CONCENTRATORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 75.SAUDI ARABIA OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2020–2030($MILLION)
TABLE 76.SAUDI ARABIA OXYGEN CONCENTRATORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 77.SAUDI ARABIA OXYGEN CONCENTRATORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 78.SOUTH AFRICA OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2020–2030($MILLION)
TABLE 79.SOUTH AFRICA OXYGEN CONCENTRATORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 80.SOUTH AFRICA OXYGEN CONCENTRATORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 81.REST OF LAMEA OXYGEN CONCENTRATORS MARKET, BY TECHNOLOGY, 2020–2030($MILLION)
TABLE 82.REST OF LAMEA OXYGEN CONCENTRATORS MARKET, BY PRODUCT, 2020–2030($MILLION)
TABLE 83.REST OF LAMEA OXYGEN CONCENTRATORS MARKET, BY END USER, 2020–2030($MILLION)
TABLE 84.CHART: COMPANY SNAPSHOT
TABLE 85.CHART: OPERATING SEGMENTS
TABLE 86.CHART: PRODUCT PORTFOLIO
TABLE 87.DEVILBISS: COMPANY SNAPSHOT
TABLE 88.DEVILBISS: OPERATING SEGMENTS
TABLE 89.DEVILBISS: PRODUCT PORTFOLIO
TABLE 90.GCE: SNAPSHOT
TABLE 91.GCE: OPERATING SEGMENTS
TABLE 92.GCE: PRODUCT PORTFOLIO
TABLE 93.INOGEN: COMPANY SNAPSHOT
TABLE 94.INOGEN: PRODUCT PORTFOLIO
TABLE 95.INVACARE: COMPANY SNAPSHOT
TABLE 96.INVACARE: OPERATING SEGMENTS
TABLE 97.INVACARE: PRODUCT PORTFOLIO
TABLE 98.PHILIPS: COMPANY SNAPSHOT
TABLE 99.PHILIPS: OPERATING SEGMENTS:
TABLE 100.PHILIPS: PRODUCT PORTFOLIO
TABLE 101.NIDEK: COMPANY SNAPSHOT
TABLE 102.NIDEK: OPERATING SEGMENTS
TABLE 103.NIDEK: PRODUCT PORTFOLIO
TABLE 104.O2 CONCEPTS: COMPANY SNAPSHOT
TABLE 105.O2 CONCEPTS: PRODUCT PORTFOLIO
TABLE 106.SUPERA: COMPANY SNAPSHOT
TABLE 107.SUPERA: PRODUCT PORTFOLIO
TABLE 108.TEIJIN: COMPANY SNAPSHOT
TABLE 109.TEIJIN: OPERATING SEGMENTS
TABLE 110.TEIJIN: PRODUCT PORTFOLIO
Similar Reports
Medical implants are permanent devices such as pacemakers or temporary devices such as fracture plates which are removed once their function is completed. These implants are made up of bone, tissue, skin, ceramics, metals, plastics, and other natural materials...
- Publish Date: August 21, 2016
- $5370
Ostomy is a surgery wherein an artificial opening, known as stoma, is created from the colon in the human body to eliminate body wastes such as urine, mucus, and stools, which are collected in artificial bags called ostomy drainage bags. These plastic/rub...
- Publish Date: December 1, 2016
- $5370
Laparoscopy is a minimally invasive procedure used to examine organs inside the abdomen or pelvic cavities by inserting a laparoscope through a small incision in the abdomen. A laparoscope comprises a long, thin tube with high-intensity light, and high-re...
- Publish Date: April 24, 2017
- $5370
